Our Data

Where Your Brand, And Your Competitors, Win Or Lose Access

Fully integrated, prescriber-level insights across pharmacy, medical, and prior authorization data.

Connected Intelligence

Forsyth’s data, Influent℠, is the connected intelligence layer that measures the full prescribing journey — from the first indication of interest to therapy adoption — refreshed daily and built for your brand and its competitors. By connecting Benefit Check activity, Prior Authorization intelligence, Claims data, and daily signals, Influent℠ helps pharma identify where demand emerges, where it breaks down, and which opportunities remain recoverable. The result is a longitudinal connected view of the prescribing journey that enables brands to quantify demand before it appears in claims and take action before opportunities are lost.

Client Portal

Inflow℠ is Forsyth Health’s client portal, designed to turn data into action. As the home of Influent℠, Inflow℠ provides a single destination to access insights, monitor market dynamics, track prescribing activity, and identify opportunities across the prescribing journey. With an intuitive user experience and actionable intelligence at your fingertips, Inflow℠ helps teams move from visibility to intervention.

Dashboard Analytics

Turn Integrated Data Into Decisions Teams Can Use

Layered analytics charts representing Forsyth dashboards built on pharmacy, medical, and prior authorization data.

Forsyth’s interactive dashboards and analytics turn data into actionable insights. Designed for speed and usability, our dashboards help your teams:

  • Track patient and prescriber access trends
  • Identify market opportunities and challenges
  • Benchmark competitor performance against therapeutic class or competitor activity

Built on integrated pharmacy, medical, and prior authorization data, Forsyth dashboards provide a clear, prescriber level view of where access breaks down and where opportunity exists. Near real time updates ensure teams are working from the most current information, enabling faster prioritization and more informed decisions across brand, market access, and field teams. With intuitive visualizations and flexible views, Forsyth makes it easy to move from insight to action — without getting lost in complexity.

Data That Quantifies Prescriber Intent

RxPA Metrics That Measure Interest, Not Only Adoption

Stethoscope beside healthcare analytics charts representing prescriber intent data.

To help quantify prescriber intent, Forsyth’s RxPA Data Metrics measure the following:

  • Attempted prior authorizations (PAs)
  • PA decisions (approvals/denials/appeals)
  • Detailed denial reasons (i.e., step therapy, clinical criteria not met)
  • Post-approval PA insights (i.e., went on brand, reversed at pharmacy, filled alternate brand)
  • Competitor RxPA insights (same insights available as your own brand)

Based On These Metrics, Our RxPA Data Enables

Practice Patterns
Identify prescriber practice patterns, measured by intent rather than adoption alone.
Sales
Identify prescribers prescribing for the wrong patient targets to educate.
Brand
Quantify the impact of campaigns on prescribers’ brand interest.
Market Access
Use data to better qualify formulary negotiation strategies.
Field Reimbursement
Target in real time the access barriers impacting pull-through.

RxPA Data Application

Product Life Cycle

Within the product life cycle, there are pre-launch, early launch, established market, and new competitor stages.

  1. Pre-Launch

    Consider competitors with high or low denial rates and develop a negotiation strategy for appropriate formulary status, to help provide an “easy button” for access.

  2. Early Launch

    Gain visibility into prescribing intent for your brand before a claim exists and learn from offices with successful practice patterns to quickly support those who are struggling. Early adopters who routinely get denied in the first 3 months are more likely to stop prescribing your brand. Knowing who they are quickly is pivotal, as claims won’t disclose whether they are struggling to get access.

  3. Established Market

    Identify why prescribers are denied for your brand and competitors. This allows you to determine if you can capitalize on their areas of weakness and if your current prescribers are struggling with appropriate patient targeting or the PA administrative process.

  4. New Competitors

    Quickly assess where your market share might be at risk, as PA attempts are the lead indicator that there is intent for a brand and can signal future shifts in market share.

Start A Conversation

Our Adaptive, Evolutionary Services Are Now Available.

Let’s partner to improve outcomes.

Prefer email? Reach us directly at info@forsythhealth.com